MiMedx Group (MDXG) Earnings Analysis

MiMedx Group (MDXG) next reports earnings on 2026-07-29, consensus EPS -0.034 USD. Last quarter (2025-07-30) it beat with EPS 0.1 USD vs 0.06 USD est (+66.7%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E 20.33.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does MDXG next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate-0.034 USD
Revenue estimate0.06B

MDXG earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2025-07-300.1 USD0.06 USD+66.7%Beat
2025-04-300.06 USD0.06 USD0%Beat
2025-02-260.07 USD0.07 USD0%Beat
2024-07-310.08 USD0.08 USD0%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

MDXG valuation and analyst view

Trailing P/E20.33
Trailing EPS0.20678 USD
Price / book2.55
Dividend yield0.00%
Market cap0.62B
Analyst consensusBuy (12 buy / 1 hold / 2 sell)
Avg price target10 USD

Related research pages

Frequently asked questions

When is MiMedx Group (MDXG)'s next earnings date?

MiMedx Group is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -0.034 USD and revenue estimate of 0.06B.

Did MDXG beat earnings last quarter?

In its 2025-07-30 report, MDXG posted EPS of 0.1 USD versus a 0.06 USD estimate — a beat of 66.7%.

What is MDXG's earnings track record?

Over the last 4 reported quarters with consensus data, MDXG beat estimates 4 times (100%).

What is MDXG's current P/E ratio and EPS?

MDXG trades at a trailing P/E of 20.33 on trailing EPS of 0.2067755041214747 USD.

What do analysts rate MDXG?

Analyst consensus is "Buy" across 15 ratings (0 strong buy, 12 buy, 1 hold, 2 sell, 0 strong sell). Average 12-month price target: 10 USD.